🏥 治験ポータル
← 治験一覧に戻る

FP-10が三剤併用療法によるピロリ菌除菌率に及ぼす影響

基本情報

NCT ID
NCT00281047
ステータス
不明
試験のフェーズ
第2/第3相
試験タイプ
介入
目標被験者数
138
治験依頼者名
Hamamatsu University

概要

FP-10 is a food ingredient derived from milk casein. FP-10 can inhibit H. pylori to attach to the gastric epithelium. FP-10 has been made clear to decrease the intragastric urease activity (which is assumed to be produced by H. pylori) measured by the urea breath test. FP-10 can also detach H. pylori from gastric epithelium. We have hypothesized that FP-10 increases the eradication rates by a triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.

対象疾患

Helicobacter Pylori

介入

FP-10(DRUG)

依頼者(Sponsor)

実施施設 (6)

大分内科腎クリニック

Ōita, Oita Prefecture, Japan(RECRUITING)

松下クリニック

Hamamatsu, Shizuoka, Japan(RECRUITING)

かとう泌尿器科・内科・外科クリニック

Hamamatsu, Shizuoka, Japan(RECRUITING)

Oita Kouseiren Tsurumi Hospital

Beppu, Oita Prefecture, Japan(RECRUITING)

中島医院

Kakegawa, Shizuoka, Japan(RECRUITING)

University Hospital of Hamamatsu University School of Medicine

Hamamatsu, Shizuoka, Japan(RECRUITING)